| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,740 | 2,880 | 11:50 |
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.01. | HAOHAI BIOTEC (06826): SUPPLEMENTAL ANNOUNCEMENT - CONNECTED TRANSACTION - ACQUISITION OF EQUITY INTEREST IN JIANGXI RUIJI BIO-ENGINEERING TECHNOLOGY ... | 3 | HKEx | ||
| 29.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 23.12.25 | HAOHAI BIOTEC (06826): OVERSEAS REGULATORY ANNOUNCEMENT - SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO., LTD.* ANNOUNCEMENT ON THE RECEIPT OF AN ADMINISTRATIVE ... | - | HKEx | ||
| 18.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 12.12.25 | HAOHAI BIOTEC (06826): CONNECTED TRANSACTION - ACQUISITION OF EQUITY INTEREST IN JIANGXI RUIJI BIO-ENGINEERING TECHNOLOGY CO., LTD.* | 1 | HKEx | ||
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 12.12.25 | HAOHAI BIOTEC (06826): CHANGE OF JOINT COMPANY SECRETARY, AUTHORIZED REPRESENTATIVE AND PROCESS AGENT | 1 | HKEx | ||
| 11.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 04.12.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 27.11.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 19.11.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 11.11.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 2 | HKEx | ||
| 07.11.25 | HAOHAI BIOTEC (06826): CONNECTED TRANSACTION - ACQUISITION OF REMAINING 20% EQUITY INTEREST IN A NON-WHOLLY OWNED SUBSIDIARY | 1 | HKEx | ||
| 03.11.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 27.10.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | 1 | HKEx | ||
| 24.10.25 | HAOHAI BIOTEC (06826): 2025 THIRD QUARTERLY REPORT | - | HKEx | ||
| 14.10.25 | HAOHAI BIOTEC (06826): DATE OF BOARD MEETING | 1 | HKEx | ||
| 24.09.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 15.09.25 | HAOHAI BIOTEC (06826): NEXT DAY DISCLOSURE RETURN | - | HKEx | ||
| 08.09.25 | HAOHAI BIOTEC (06826): INTERIM REPORT 2025 | - | HKEx | ||
| 05.09.25 | Dividendenbekanntmachungen (05.09.2025) | 13.287 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AAON INC US0003602069 0,1 USD 0,0858 EUR ACUSHNET HOLDINGS CORP US0050981085 0,235 USD 0,2017 EUR AIA GROUP LTD HK0000069689 0... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| VALNEVA | 3,988 | +0,81 % | Valneva zieht US-Zulassungsanträge für IXCHIQ zurück - Aktie unter Druck | Die Valneva SE hat die Zulassungsanträge (BLA und IND) für ihren Chikungunya-Impfstoff IXCHIQ in den USA freiwillig zurückgezogen. Hintergrund sind regulatorische Maßnahmen der U.S. Food and Drug Administration... ► Artikel lesen | |
| AMGEN | 294,25 | -0,03 % | Amgen (AMGN): Ausbruch geglückt - Warum Trader jetzt die Marke von 345 USD genau im Auge behalten. | Perfekte Einstiegschance nach dem Pullback? Rückblick Amgen ist ein führendes Biotechnologieunternehmen und setzt stark auf Medikamente wie MariTide (Gewichtsverlust-Kandidat), das direkt mit den Produkten... ► Artikel lesen | |
| STRYKER | 302,10 | +0,57 % | Teledyne FLIR Defense Wins $32 Million Contract to Provide Recon Surveillance Kit on Strykers for Bulgaria | Advanced sensor suite will add situational awareness capabilities to Stryker armored vehicles, including 360-degree visibility, thermal imaging, and long-range threat detection
Teledyne FLIR Defense... ► Artikel lesen | |
| REGENERON PHARMACEUTICALS | 639,40 | -0,37 % | BofA Securities reiterates Buy rating on Regeneron stock with $860 price target | ||
| EXACT SCIENCES | 86,15 | -0,12 % | Assessing Exact Sciences: Insights From 16 Financial Analysts | ||
| CSL | 107,30 | +0,96 % | Here are the latest growth forecasts for the CSL share price | ||
| BEONE MEDICINES LTD ADR | 282,00 | -0,70 % | BeOne Medicines Ltd.: BeOne Medicines demonstriert seine globale Marktführerschaft im Bereich Onkologie auf der 44. jährlichen J.P. Morgan Healthcare Conference | Das Unternehmen unterstreicht seine führende Position auf dem Gebiet der Hämatologie, präsentiert mehrere Datenkatalysatoren für 2026 und hebt seinen einzigartigen globalen Superhighway für klinische... ► Artikel lesen | |
| CANSINO BIOLOGICS | 4,072 | -4,01 % | CANSINOBIO Expects 2025 to Swing to Profit of at Least RMB24.5M | ||
| SINO BIOPHARM | 0,700 | +1,13 % | SINO BIOPHARM's TQA3605 'Core Protein Allosteric Modulator' for Chronic Hepatitis B Achieves Primary Endpoint in Phase II Clinical Trials | ||
| BIOMERIEUX | 103,10 | -0,19 % | BIOMERIEUX: bioMérieux Acquires Accellix to Elevate Pharmaceutical Quality Control and Accelerate Advanced Therapies | ||
| ZAI LAB LTD ADR | 14,800 | -0,67 % | Zai Lab's Augtyro receives NMPA approval for solid tumours in China | ||
| CSTONE PHARMACEUTICALS | 0,570 | -4,20 % | CSTONE PHARMA-B (02616): VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY CEO AND EXECUTIVE DIRECTOR DR. JIANXIN YANG BY 976,000 SHARES, WITH ACCUMULATED ... | ||
| CASI PHARMACEUTICALS | 0,980 | +2,08 % | CASI Pharmaceuticals, Inc. - 6-K, Report of foreign issuer | ||
| 3SBIO | 2,540 | -2,31 % | 3SBio Sells Shares, Divests Subsidiary To Boost Capital | ||
| GENSCRIPT BIOTECH | 1,393 | 0,00 % | GENSCRIPT BIO (01548): VOLUNTARY ANNOUNCEMENT: APPOINTMENT OF DIRECTOR BY LEGEND BIOTECH CORPORATION |